Publications

Project

Clinical Trial Participation and Health Behavior Modification: Secondary Prevention of Small Subcortical Strokes (SPS3)

Lau H, White CL, Coffey C, Kase CS, Babikian VL et al.

J Neurol Disord Stroke. 2015; 3 (1) 1094.

2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients with Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American

Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, Johnston KC, Johnston SC, Khalessi AA, Kidwell CS, Meschia JF, Ovbiagele B, and Yavagal DR on Behalf of the American Heart Association Stroke Council

Stroke. 2015 June 29; 46 (10) 3020-3035.

PubMed:

26123479

A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence

Carter BL, Coffey CS, Chrischilles EA, Ardery G, Ecklund D, Gryzlak B, Vander Weg MW, James PA, Christensen AJ, Parker CP, Gums T, Finkelstein RJ, Uribe L, Polgreen LA, MEDication Focused Outpatient Care for Underutilization of Secondary Prevention Trial Investigators

Pharmacotherapy. 2015 June 25; 35 (7) 653-62.

PubMed:

PMC4686257

Correlates of Excessive Daytime Sleepiness in De Novo Parkinson’s Disease: A Case Control Study

Simuni T, Caspell-Garcia C, Coffey C, Chahine LM, Lasch S, Oertel WH, Mayer G, Hogl B, Postuma R, Videnovic A, Amara AW, and Marek K for the PPMI Sleep Working Group on Behalf of the PPMI Investigators

Movement Disorders. 2015 June 11; 30 (10) 1371-1381.

PubMed:

PMC4822999

Cognitive Performance and Neuropsychiatric Symptoms in Early, Untreated Parkinson Disease

Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, Richard I, Troyer MD, Hawkins, KA, and the Parkinson’s Progression Markers Initiative

Movement Disorders. 2015 June; 30 (7) 919-927.

PubMed:

PMC4855523

Pharmacist Intervention for Blood Pressure Control: Medication Intensification and Adherence

Gums TH, Uribe L, Vander Weg MW, James P, Coffey C, and Carter BL

Journal of the American Society for Hypertension. 2015 May 15; 9 (7) 569-578.

PubMed:

PMC4508208

Diffusion Tensor Imaging of the Nigrostriatal Fibers in Parkinson’s Disease

Zhang Y, Wu IW, Buckley S, Coffey CS, Foster E, Mendick S, Seibyl J, and Schuff N

Movement Disorders. 2015 April 29; 30 (9) 1229-1236.

PubMed:

PMC4418199

Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases

Wanner A, Groft SC, Teagarden JR, Krischer J. Davis BR, Coffey CS, Hickam DH, Teckman J, Nelson DR, McCaleb ML, Loomba R, Strange C, Sandhaus RA, Brantly M, Edelman JM, and Farrugia A

Chronic Obstructive Pulmonary Diseases. 2015 April 28; 2 (2) 177-190.

PubMed:

PMC5556970

Consistency of quantitative scores of hypoglycemia severity and glycemic lability and comparison with continuous glucose monitoring system measures in long-standing type 1 diabetes

Senior PA, Bellin MD, Alejandro R, Yankey JW, Clarke WR, Qidwai JC, Schwieger TR, Eggerman TL, Robien MA, Rickels MR, Clinical Islet Transplantation Consortium

Diabetes Technology & Therapeutics. 2015 April; 17 (4) 235-42.

PubMed:

PMC4447028

A Cluster-Randomized Trial of a Physician/Pharmacist Collaborative Model to Improve Blood Pressure Control

Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, Egan B, Vander Weg M, Chrischilles E, and Vaughn T

Circulation: Cardiovascular Quality & Outcomes. 2015 March 24; 8 (3) 235-243.

PubMed:

PMC4618490

You are here

Publications